US Patent Issued to Dyne Therapeutics on March 4 for "Muscle targeting complexes and uses thereof for treating dystrophinopathies" (Massachusetts Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,717, issued on March 4, was assigned to Dyne Therapeutics Inc. (Waltham, Mass.).

"Muscle targeting complexes and uses thereof for treating dystrophinopathies" was invented by Romesh R. Subramanian (Framingham, Mass.), Mohammed T. Qatanani (Waltham, Mass.), Timothy Weeden (Waltham, Mass.), Cody A. Desjardins (Waltham, Mass.), Brendan Quinn (Waltham, Mass.) and John Najim (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the disclosure relate to complexes comprising a muscle-targeting agent covalently linked to a molecular payload. In some embodiments, the muscle-targeting agent specifically binds to an internalizing cell surfa...